Skip to content

Author

R. Veerabathiran

We have 6 of 103 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Association of APOE ε4 gene polymorphisms with myocardial infarction susceptibility: an updated meta-analysis with ethnicity stratification and credibility ceiling analysis

Myocardial infarction (MI) is a leading cause of disability and death worldwide. Apolipoprotein E (APOE) plays a key role in lipid metabolism, and its genetic polymorphisms have been implicated in atherosclerosis and coronary artery diseases. However, the association between the APOE ε4 polymorphism and MI risk remains...

P. K. Chandra Sekar, R. Veerabathiran · 0 citations
Review Aug 2026

Oncogenic Signalling and Immune Checkpoint Crosstalk in Cancer: Emerging Targets and Precision Therapeutic Strategies.

INTRODUCTION Cancer progression is sustained by complex interactions between oncogenic signaling pathways and immune checkpoint networks, yet their mechanistic crosstalk remains poorly integrated in existing reviews. This review synthesises the bidirectional regulatory relationships between oncogenic signaling and immu...

Praveen Kumar Chandra Sekar, R. Veerabathiran · 0 citations
Review Open access Jun 2026

Association of the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism with Increased Susceptibility to Vasculitis: A Systematic Review and Meta-Analysis

Objective: This meta-analysis aimed to evaluate the association between the angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism and susceptibility to vasculitis, including Henoch– Schönlein purpura (HSP), Henoch–Schönlein purpura nephritis (HSPN), and Behçet’s disease (BD). Methods: Relevant studi...

Praveen Kumar Chandra Sekar, R. Veerabathiran · 0 citations
Review Open access Sep 2026

Protective association of the ELMO1 rs741301 variant against diabetes mellitus and diabetic nephropathy: a systematic meta-analysis of case-control studies.

It is suggested that the ELMO1 rs741301 polymorphism may be associated with a reduced susceptibility to DN among individuals with DM and may help improve understanding of the genetic factors underlying diabetic complications.

Sheena Mariam Thomas, Anu Shibi Anilkumar, R. Veerabathiran · 0 citations
Review Open access Aug 2026

Engineering strategies and translational progress in targeted nanoparticle drug delivery.

This review comprehensively examines major nanocarrier platforms, including lipid-based, polymeric, inorganic, and hybrid systems, with emphasis on their structural design and functional properties.

Nithya Ajay, Anu Shibi Anilkumar, R. Veerabathiran · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.